Purification and labeling strategies for 68Ga from 68Ge/68Ga generator eluate

Recent Results in Cancer Research

Volumn 194, Issue , 2013, Pages 77-87

  Mueller, Dirk ^a   Klette, Ingo ^a   Baum, Richard P ^a  

^a ZENTRALKLINIK BAD BERKA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; GALLIUM 68; GALLIUM BIPHOSPHATE MONOAMIDE DERIVATIVE GA 68; GERMANIUM; GERMANIUM 68; HELIUM; RADIOPHARMACEUTICAL AGENT; TETRAXETAN; UNCLASSIFIED DRUG;

ANION EXCHANGE; ARTICLE; CONCENTRATION (PARAMETERS); ELUTION; HISTORY OF MEDICINE; ISOTOPE LABELING; MATERIALS TESTING; MOLECULAR IMAGING; PH MEASUREMENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PRODUCT SAFETY; PURIFICATION; QUALITY CONTROL; RADIOACTIVITY; RADIOASSAY; REACTION TIME; RELIABILITY; REPRODUCIBILITY; THIN LAYER CHROMATOGRAPHY;

EID: 84867052177     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-27994-2_5     Document Type: Article

References (13)

1. Baum RP, Prasad V, Müller D, Schuchardt C, Orlova A, Wennborg A, Tolmachev V, Feldwisch J (2010) Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68 Ga-labeled affibody molecules. J Nucl Med 51:892-897
2. Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Radiolabeling DOTA-peptides with 68 Ga. Eur J Nucl Med Mol Imaging 32:478-485
3. de Blois E, Sze Chan H, Naidoo C, Prince D, Krenning EP, Breeman WA (2011) Characteristics of SnO2 based 68Ge/68Ga generator and aspects of radiolabeling DOTA-peptides. Appl Radiat Isot 69:308-315
4. Fellner M, Baum RP, Kubcek V, Hermann P, Lukes I, Prasad VFR (2010) PET/CT imaging of osteoblastic bone metastases with 68 Ga-bisphosphonates: First human study. Eur J Nucl Med Mol Imaging 37:834
5. Hnatowich DJ (1975) A method for the preparation and quality control of 68Ga radiopharmaceuticals. J Nucl Med 16:764
6. Meyer GJ, Mäcke H, Schuhmacher J, Knapp WH, Hofmann M (2004) 68 Ga-labelled DOTA- derivatised peptide ligands. Eur J Nucl Med Mol Imaging 31:1097-1104 (Pubitemid 39050176)
7. Mueller D, Klette I, Wortmann R, Baum RP (2006) Markierung von DOTA-peptiden mit gallium- 68 für die nuklearmedizinische Routinediagnostik. Nuklearmedizin 45:A88-A89
8. Mueller D, Klette I, Gottschaldt M, Baum RP (2009) Radiolabeling of fragile macroligands with 68Ga. J Labelled Compd Radiopharm 52:477
9. Prasad V, Baum RP (2010) Biodistribution of the Ga-68 labeled somatostatin analogue DOTA- NOC in patients with neuroendocrine tumors: Characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging 54:61-67
10. Rösch F (2011) 68Ge/68Ga- generators-past, present and future. World J Nucl Med 10:26
11. Sainz-Esteban A, Prasad V, Baum RP (2010) Interesting image. Pancreatic neuroendocrine tumor with involvement of the inferior mesenteric vein diagnosed by Ga-68 DOTA-TATE PET/CT. Clin Nucl Med 35:40-41
12. Tolmachev V, Altai M, Sandström M, Perols A, Eriksson Karlström AH, Boschetti F, Orlova A (2011) Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody molecules. Bioconjug Chem 22:894-902
13. Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rösch F (2007) Processing of generator produced 68 Ga for medical application. J Nucl Med 48:1741-1748 (Pubitemid 47572722)